Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CALISTO: fondaparinux vs placebo in superficial thrombophlebitis of the leg
2006-004774-27Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2006
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Superficial Phlebitis comparing Fondaparinux 2.5 mg with Placebo (2 arms). Started Nov 2006; status: completed.
02
Drugs
fondaparinux
03
Conditions
Superficial Phlebitis
Beyond the preview
Go deeper on 2006-004774-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004774-27.